Back to Trades
Doyle John Brendan
Chief Financial OfficerCIK 0001840738
Profile
- Filings
- 5
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Doyle John Brendan, Chief Financial Officer, has disclosed $61.1K in transactions — all concentrated in COGNITION THERAPEUTICS INC (CGTX). Their disclosed trades are heavily weighted toward buying — $11.3K in buys and $0 in sells. The largest single open-market purchase on record is $11.3K in COGNITION THERAPEUTICS INC. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Apr 20 | CGTX COGNITION THERAPEUTICS INC | Doyle John Brendan | Chief Financial Officer | Buy | $11.3K |
| Feb 18 | CGTX COGNITION THERAPEUTICS INC | Doyle John Brendan | Chief Financial Officer | Tax withheld | $1.7K |
| Feb 5 | CGTX COGNITION THERAPEUTICS INC | Doyle John Brendan | Chief Financial Officer | Grant | $27.7K |
| Dec 22 | CGTX COGNITION THERAPEUTICS INC | Doyle John Brendan | Chief Financial Officer | Grant | $14.0K |
| Jul 31 | CGTX COGNITION THERAPEUTICS INC | Doyle John Brendan | Chief Financial Officer | Grant | $6.3K |
5 filings